David W. Gjertson

4.3k total citations
63 papers, 2.6k citations indexed

About

David W. Gjertson is a scholar working on Epidemiology, Immunology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David W. Gjertson has authored 63 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 17 papers in Immunology and 16 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David W. Gjertson's work include Renal Transplantation Outcomes and Treatments (12 papers), Organ Donation and Transplantation (8 papers) and Immune Cell Function and Interaction (8 papers). David W. Gjertson is often cited by papers focused on Renal Transplantation Outcomes and Treatments (12 papers), Organ Donation and Transplantation (8 papers) and Immune Cell Function and Interaction (8 papers). David W. Gjertson collaborates with scholars based in United States, Taiwan and Singapore. David W. Gjertson's co-authors include Elaine F. Reed, Paul I. Terasaki, Jonathan Goldin, Matthew S. Brown, Michael F. McNitt‐Gray, Yael Korin, Michael Cecka, Ram Raj Singh, Maida Wong and Jonathan Braun and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American Statistical Association.

In The Last Decade

David W. Gjertson

62 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David W. Gjertson United States 31 753 600 509 478 365 63 2.6k
Myriam Remmelink Belgium 33 827 1.1× 510 0.8× 433 0.9× 782 1.6× 475 1.3× 139 3.4k
Hubert Nivet France 28 623 0.8× 890 1.5× 401 0.8× 345 0.7× 232 0.6× 99 3.1k
Norio Yoshimura Japan 29 324 0.4× 620 1.0× 987 1.9× 1.1k 2.3× 302 0.8× 241 3.2k
Mariam P. Alexander United States 31 837 1.1× 211 0.4× 214 0.4× 461 1.0× 274 0.8× 126 3.5k
Éric Rondeau France 47 885 1.2× 1.7k 2.8× 1.1k 2.1× 925 1.9× 717 2.0× 251 6.3k
Helmut Hopfer Switzerland 33 537 0.7× 714 1.2× 1.1k 2.1× 751 1.6× 423 1.2× 94 5.0k
Jonathan D’Cunha United States 35 1.6k 2.1× 500 0.8× 430 0.8× 2.0k 4.3× 245 0.7× 207 4.5k
David Ribes France 34 366 0.5× 1.1k 1.8× 745 1.5× 375 0.8× 650 1.8× 119 3.8k
Michael B. Stokes United States 42 1.4k 1.8× 1.1k 1.9× 530 1.0× 625 1.3× 355 1.0× 106 6.1k
Volker Witt Austria 21 360 0.5× 967 1.6× 145 0.3× 456 1.0× 434 1.2× 61 3.4k

Countries citing papers authored by David W. Gjertson

Since Specialization
Citations

This map shows the geographic impact of David W. Gjertson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David W. Gjertson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David W. Gjertson more than expected).

Fields of papers citing papers by David W. Gjertson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David W. Gjertson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David W. Gjertson. The network helps show where David W. Gjertson may publish in the future.

Co-authorship network of co-authors of David W. Gjertson

This figure shows the co-authorship network connecting the top 25 collaborators of David W. Gjertson. A scholar is included among the top collaborators of David W. Gjertson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David W. Gjertson. David W. Gjertson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zheng, Ying, Maura Rossetti, Felicia Ruffin, et al.. (2025). Early cytokine signatures and clinical phenotypes discriminate persistent from resolving MRSA bacteremia. BMC Infectious Diseases. 25(1). 231–231.
2.
Pickering, Harry, Richard Ahn, Maura Rossetti, et al.. (2024). Integrated transcriptomic analysis reveals immune signatures distinguishing persistent versus resolving outcomes in MRSA bacteremia. Frontiers in Immunology. 15. 1373553–1373553. 2 indexed citations
3.
Parmar, Rajesh, Harry Pickering, David W. Gjertson, et al.. (2023). Integrated transcriptomic analysis reveals T and B cell immune signatures influencing resolving outcome in MRSA bacteremia. The Journal of Immunology. 210(Supplement_1). 233.06–233.06. 1 indexed citations
5.
Samiei, Alireza, David W. Gjertson, Sanaz Memarzadeh, Gottfried E. Konecny, & Neda A. Moatamed. (2022). Expression of immune checkpoint regulators, programmed death-ligand 1 (PD-L1/PD-1), cytotoxic T lymphocyte antigen 4 (CTLA-4), and indolaimine-2, 3-deoxygenase (IDO) in uterine mesenchymal tumors. Diagnostic Pathology. 17(1). 70–70. 3 indexed citations
6.
Ahn, Richard, Joanna Schaenman, Harry Pickering, et al.. (2021). Acute and Chronic Changes in Gene Expression After CMV DNAemia in Kidney Transplant Recipients. Frontiers in Immunology. 12. 750659–750659. 9 indexed citations
7.
Aziz, Najib, Roger Detels, Joshua Quint, et al.. (2016). Stability of cytokines, chemokines and soluble activation markers in unprocessed blood stored under different conditions. Cytokine. 84. 17–24. 71 indexed citations
8.
Schaenman, Joanna, Yael Korin, David W. Gjertson, et al.. (2016). Increased Frequency of BK Virus-Specific Polyfunctional CD8+ T Cells Predict Successful Control of BK Viremia After Kidney Transplantation. Transplantation. 101(6). 1479–1487. 38 indexed citations
9.
Kim, Hyun J., Donald P. Tashkin, David W. Gjertson, et al.. (2016). Transitions to different patterns of interstitial lung disease in scleroderma with and without treatment. Annals of the Rheumatic Diseases. 75(7). 1367–1371. 38 indexed citations
10.
Kim, Hyun J., Hyun J. Kim, Matthew S. Brown, et al.. (2014). Comparison of the Quantitative CT Imaging Biomarkers of Idiopathic Pulmonary Fibrosis at Baseline and Early Change with an Interval of 7 Months. Academic Radiology. 22(1). 70–80. 97 indexed citations
11.
Veena, Mysore S., Saroj K. Basak, Eugene Han, et al.. (2011). Curcumin Treatment Suppresses IKKβ Kinase Activity of Salivary Cells of Patients with Head and Neck Cancer: A Pilot Study. Clinical Cancer Research. 17(18). 5953–5961. 96 indexed citations
12.
Jindra, Peter, David W. Gjertson, Xiu-Da Shen, et al.. (2008). Anti-MHC Class I Antibody Activation of Proliferation and Survival Signaling in Murine Cardiac Allografts. The Journal of Immunology. 180(4). 2214–2224. 87 indexed citations
13.
Levinson, Ralph D., Zhonglin Du, Lihui Luo, et al.. (2008). Combination of KIR and HLA gene variants augments the risk of developing birdshot chorioretinopathy in HLA-A*29-positive individuals. Genes and Immunity. 9(3). 249–258. 35 indexed citations
14.
Kim, Hyun J., Gang Li, David W. Gjertson, et al.. (2008). Classification of Parenchymal Abnormality in Scleroderma Lung Using a Novel Approach to Denoise Images Collected via a Multicenter Study. Academic Radiology. 15(8). 1004–1016. 58 indexed citations
15.
Wong, Maida, David Ziring, Yael Korin, et al.. (2007). TNFα blockade in human diseases: Mechanisms and future directions. Clinical Immunology. 126(2). 121–136. 236 indexed citations
16.
Du, Zeying, David W. Gjertson, Elaine F. Reed, & Raja Rajalingam. (2006). Receptor-ligand analyses define minimal killer cell Ig-like receptor (KIR) in humans. Immunogenetics. 59(1). 1–15. 112 indexed citations
17.
Brown, Matthew S., Jonathan Goldin, Xiaohong Yan, et al.. (2004). Comparison of treatment response classifications between unidimensional, bidimensional, and volumetric measurements of metastatic lung lesions on chest computed tomography1. Academic Radiology. 11(12). 1355–1360. 96 indexed citations
18.
Mao, Jenny T., Jonathan Goldin, John Dermand, et al.. (2002). A Pilot Study of All- trans -Retinoic Acid for the Treatment of Human Emphysema. American Journal of Respiratory and Critical Care Medicine. 165(5). 718–723. 125 indexed citations
19.
Scantlebury, Velma P., David W. Gjertson, Michael Eliasziw, et al.. (1998). EFFECT OF HLA MISMATCH IN AFRICAN-AMERICANS1. Transplantation. 65(4). 586–588. 25 indexed citations
20.
Scantlebury, Velma P., David W. Gjertson, Michael Eliasziw, et al.. (1997). Influence of HLA and CREG matching in African-American primary cadaver kidney recipients: UNOS 1991–1995. Transplantation Proceedings. 29(8). 3733–3736. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026